Glutathione peroxidase mimics prevent TNFalpha- and neutrophil-induced endothelial alterations.
Based on the assumption that glutathione peroxidase (GPx) activity might be limiting in preventing peroxide-induced impairment of endothelial regulatory functions, we studied the effect of a series of new selenium-containing GPx mimics on endothelial cells exposed to an inflammatory stress. The two compounds that have the highest GPx activity, BXT-51072 and BXT-51077, were shown to be the most efficient inhibitors of leukocyte recruitment by human umbilical vein endothelial cells (HUVEC), upon incubation with neutrophils (10-fold excess over HUVEC) and with 1 ng/ml TNF-alpha for 1 or 3.5 h. When HUVEC were pre- and cotreated with 10 microM of either compound, neutrophil adhesion and endothelial alteration were markedly inhibited, as assessed by immunoassays of myeloperoxidase and von Willebrand factor, respectively. These two GPx mimics were also found to be the most efficient inhibitors of the TNFalpha-induced endothelial expression of P- and E-selectin and of the TNFalpha- or interleukin1-induced endothelial release of interleukin-8. Our results demonstrate that GPx mimics such as BXT-51072 behave as potent antagonists of TNF-alpha and interleukin-1 through the downregulation of endothelial proinflammatory responses.
Centre de Recherche Oxis International SA, Bonneuil-sur-Marne, France.
M
M
Moutet
P
P
d'Alessio
P
P
Malette
V
V
Devaux
J
J
Chaudière
D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology; D001393:Azoles / Q000737:chemistry / Q000494:pharmacology*; D002478:Cells, Cultured; D019040:E-Selectin / Q000378:metabolism; D004730:Endothelium, Vascular / Q000502:physiology*; D005979:Glutathione Peroxidase / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007375:Interleukin-1 / Q000494:pharmacology; D016209:Interleukin-8 / Q000378:metabolism; D054833:Isoindoles; D018375:Neutrophil Activation; D009504:Neutrophils / Q000502:physiology*; D016566:Organoselenium Compounds / Q000737:chemistry / Q000494:pharmacology*; D019007:P-Selectin / Q000378:metabolism; D018036:Selenium Compounds / Q000737:chemistry / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014471:Umbilical Veins; D014841:von Willebrand Factor / Q000378:metabolism
D000975:Antioxidants; D001393:Azoles; C114696:BXT 51077; D019040:E-Selectin; D007375:Interleukin-1; D016209:Interleukin-8; D054833:Isoindoles; D016566:Organoselenium Compounds; D019007:P-Selectin; D018036:Selenium Compounds; D014409:Tumor Necrosis Factor-alpha; D014841:von Willebrand Factor; C042986:ebselen; C114695:BXT 51072; D005979:Glutathione Peroxidase